- •Acknowledgment
- •Abbreviations and Glossary
- •Contents
- •Introduction
- •1: Should You Become a VR Surgeon?
- •2.2 A Word of Caution
- •Introduction
- •3: Fundamental Rules for the VR Surgeon
- •3.4 The “What, When, How – and Why” Questions
- •3.5 Don’t Start What You Cannot Finish
- •3.6 Common Sense vs Dogma
- •3.7 Maximal Concentration During the Entire Operation
- •3.8 Make Life as Easy for Yourself as Possible
- •3.9 Under Peer Pressure: To Yield or Not to Yield
- •3.10 Referral of the Patient
- •3.11 The Rest of the Eyeball…
- •4.1 What If the Surgeon Has Tremor?
- •4.2 How Important Is Good Dexterity?
- •4.5 Combined Surgery or Cataract Surgery Separately?
- •4.7 How Much Confidence in Himself Should the VR Surgeon Have?
- •4.8 How Long Do Vitrectomies Take?
- •4.9 Was Surgery Successful?
- •5.1 The “Target” of Counseling
- •5.2 The Patient Does Not Know Most of What Is so Obvious to the Surgeon
- •5.3 Communicating with the Patient
- •5.4 Coaching vs Trying to Be Objective
- •5.5 The Ultimate Treatment Decision: “Whose Eye Is It?”
- •5.6 Which of the Two Eyes to Operate on First?
- •5.7 What if the Eye Has Two Diseases?
- •5.8 What if the Eye Has Severe Visual Loss and the Chance of Improvement with Another Surgery Is Low?
- •5.9 Empathy: The Single Most Important Component of Counseling
- •5.10 The Prognosis with the Chosen Surgical Option
- •5.11 If the Patient Chooses to Undergo Surgery
- •5.12 The Benefits of Proper Counseling
- •5.14 The Dogmas
- •6: The VR Surgeon’s Relation to His Nurse
- •7: Examination
- •8: The Indication Whether to Operate
- •8.1 The Argument in Favor of Surgery
- •8.3 The Age of the Patient
- •8.4 The Condition of the Fellow Eye
- •11: The Surgeon’s Relation to Himself
- •11.3 Self-Examination
- •Introduction
- •12.1.1 The Pump
- •12.1.1.1 Peristaltic Pump: Flow Control
- •12.1.2 The Probe
- •12.1.2.2 Port Location
- •12.1.2.3 Port Configuration and Size
- •12.1.2.4 Cut Rate
- •12.1.2.6 Probe Length
- •12.1.3 The Light Source/Pipe
- •12.1.4 The Infusion Supply
- •12.1.5 The Trocar
- •12.1.6 The Cannula
- •12.1.7 System to Inject/Extract Viscous Fluid
- •12.1.8 The Pedal
- •12.1.10 Endodiathermy Probe
- •12.1.11 The User Interface of the Vitrectomy Console
- •12.1.12 Troubleshooting
- •12.2 The Microscope
- •13: Instruments, Tools, and Their Use
- •13.2.1.1 General Concepts of Working with Squeezable Instruments
- •13.2.1.2 The Handle
- •13.2.1.3 Forceps
- •13.2.1.4 Scissors
- •13.2.2 Hybrid Instruments
- •13.2.2.2 Retractable Instruments
- •13.2.3 Non-squeezable Hand Instruments
- •13.2.3.1 Bent (Hooked, Barbed) Needle
- •13.2.3.2 Membrane Scraper
- •13.2.3.3 Spatula/Pic
- •13.2.3.4 Intraocular Magnet
- •13.3.1 Membrane Dissection (“Viscosurgery”): Viscoelastics as a Spatula
- •13.3.2 Opening a Closed Funnel
- •14: Materials and Their Use
- •14.2 Intravitreal Gas
- •14.3 Silicone Oil
- •14.3.1 Types of Silicone Oil
- •14.3.3 Complications Related to Silicone Oil Use
- •14.3.4 Complications Related to Silicone Oil Use Removal
- •14.4 PFCL
- •14.6 Sutures
- •15: Anesthesia
- •15.1 How to Decide the Type of Anesthesia
- •15.2 If Local Anesthesia Is Chosen
- •15.3 Medications If Local Anesthesia Is Used
- •16: The Surgeon at the Operating Table
- •16.1 The OR Personnel
- •16.2 The Operating Table and the Surgeon’s Chair
- •16.2.1 The Operating Table
- •16.2.2 The Surgeon’s Chair
- •16.4 The Microscope
- •16.5 The BIOM
- •16.5.1 BIOM: The Advantages
- •16.5.2 BIOM Use: Practical Information
- •16.5.3 BIOM: Setting Up for Daily Use
- •16.5.4 BIOM: Checklist
- •16.5.5 BIOM: Troubleshooting
- •16.6 The Patient
- •16.7 The Surgeon
- •16.7.2 At the Start of Vitrectomy
- •16.7.3 Staring into the Microscope
- •16.8 Music in the OR
- •16.9 The Brightness in the OR
- •16.10 The Quality of the Air in the OR
- •16.12 The Blueprint of the OR
- •16.13 The Captain in the OR
- •16.14 The Fundamental Technical Rules of Performing Intravitreal Surgery
- •Introduction
- •17.3 The Endoscope Approach (EAV)
- •17.4 Portable Systems
- •17.5 3D Viewing
- •18.1 Disinfection and Draping
- •18.2 The Monocular Patient
- •18.3 At the Conclusion of the Operation
- •19: The Speculum and Its Placement
- •19.1 General Considerations
- •19.2 Speculum Placement
- •20.3 Injecting into the Vitreous Cavity During Surgery
- •21: Sclerotomies and the Cannulas
- •21.2 Location of the Sclerotomies
- •21.2.1 Distance from the Limbus
- •21.2.2 Location in Clock Hours
- •21.2.3 In Case of a Reoperation
- •21.2.4 In Case of Scleral Thinning
- •21.3 Inserting the Cannula
- •21.4 The Order of Cannula Placement
- •21.5 If the Palpebral Opening Is Small
- •21.6 Checking the (Infusion) Cannula
- •21.6.1 Cannula Under the Choroid/Retina: Prevention
- •21.6.2 Cannula Under the Choroid/Retina: Management
- •21.6.3 Infusion Going Under the Choroid/Retina: Management
- •21.7 The Cannulas in Use
- •21.8 The Removal of the Cannulas
- •21.8.1 Hypotony: The Causes
- •21.8.2 Hypotony: The Consequences
- •21.8.3 Hypotony: Prevention
- •21.8.4 Hypotony: Postoperative Management
- •22: Illumination
- •22.1 The Light Pipe
- •22.3 Light Built into the Handheld Instruments
- •24: Using the Vitrectomy Probe
- •24.1 Removal of the Vitreous
- •24.2 Removal of Proliferative Membranes
- •24.3 Removal of the Retina
- •24.4 Removal of the Lens
- •25: Maintaining Good Visualization
- •25.1.1 The Microscope
- •25.1.2 The Contact Lens
- •25.1.3 The Corneal Surface
- •25.1.4 The Corneal Stroma
- •25.2 Internal Factors
- •25.2.2 Pupil
- •25.2.2.1 Mechanical Forces Preventing Pupil Dilation
- •25.2.2.2 Intracameral Adrenalin or Visco
- •25.2.2.4 Iris Ring
- •25.2.2.5 Iridotomy
- •25.2.3 Lens
- •25.2.3.1 Cataract
- •25.2.3.2 “Feathering”
- •25.2.3.3 “Gas Cataract”
- •25.2.3.4 “Lens Touch”
- •25.2.4.1 Phimosis of the Anterior Capsule
- •25.2.4.2 Deposit on the Anterior IOL Surface
- •25.2.4.3 Problems with the IOL Itself
- •25.2.4.4 Fluid Condensation
- •25.2.5 The Posterior Capsule
- •25.2.6 The Vitreous Cavity
- •25.2.7 Epiretinal (Subhyaloidal) Materials
- •25.2.7.1 Blood
- •25.2.8 The Surgeon’s Actions
- •25.2.9 “Chromovitrectomy”
- •26.1.1 Vitreous Macroanatomy
- •26.1.2 Vitreous Biochemistry and Its Anatomical and Functional Implications
- •26.1.3 Retinal Histology and Macroanatomy
- •26.1.4 Anterior Segment Dimensions
- •26.2 External Anatomy for the VR Surgeon
- •26.3 Physiology: What Keeps the Retina Attached?
- •26.3.1 The RPE Pump
- •26.3.3 Presence of the Vitreous Gel
- •27: The Basics of Vitreous Removal
- •27.1 The Rationale for PPV
- •27.2 How Much Vitreous to Remove?
- •27.3 Recognizing the Presence of the Vitreous Gel
- •27.3.1 Mechanical Aids
- •27.3.2 Air (Pneumovitrectomy)
- •27.3.3 Stains and Markers
- •27.4 The Sequence of Vitreous Removal
- •27.5.2 Vitrectomy Anterior to the Equator
- •27.5.3 Vitrectomy Behind the Lens
- •28: Scleral Indentation
- •28.1 The Advantages of Scleral Indentation
- •28.2 The Mechanics of Vitrectomy with Scleral Indentation
- •28.3 Internal vs External Illumination
- •28.5 External Illumination and Nurse Indentation
- •28.6 Instrumentation and Technique
- •29: Cryopexy
- •29.1 Indication in RD
- •29.2 Surgical Technique
- •29.3 Cryopexy as a Destructive Force
- •30: Endolaser
- •30.1 The Consequences of Laser Treatment
- •30.2 The Setup
- •30.3 The Technique of Endolaser Treatment
- •30.3.1 General Considerations
- •30.3.2 Panretinal Treatment
- •30.3.3 Endolaser Cerclage and Its Complications
- •30.3.4 Endolaser as a Walling-Off (Barricading) Tool
- •30.3.5 Endolaser as a Welding Tool
- •30.4 Peripheral Laser and the Beginner VR Surgeon
- •30.5 Endocyclophotocoagulation
- •30.6 Laser Cerclage at the Slit Lamp
- •31: Working With and Under Air
- •31.1.1 Attached Retina
- •31.3 The Utilization of an Air Bubble
- •32: Working with Membranes
- •32.1.1 Instrumentation and Infrastructure
- •32.1.2 Opening the ILM
- •32.1.2.1 Sharp Opening: Incision First
- •32.1.2.2 Blunt Opening: No Incision
- •The Scraper
- •32.1.3 Peeling the Membrane
- •32.1.4 The Extent of ILM Peeling
- •32.1.5 What If the ILM Cannot Be Peeled?
- •32.1.6 ILM Removal in Eyes with Detached Macula
- •32.1.6.1 Reattaching the Macula First
- •32.1.6.2 Peeling When the Macula Is Still Detached
- •32.2.2 Removal Technique
- •32.2.2.1 Staining or Not?
- •32.2.2.2 Instrumentation
- •32.2.2.3 Location of the Point of Attack
- •32.2.2.4 The Major Risks When First Grabbing an EMP
- •32.2.2.5 The Direction of Peeling: Centripetal vs Centrifugal
- •32.2.2.6 The Speed of Peeling
- •32.2.2.7 The Extent of Peeling
- •32.2.2.8 ILM Peeling
- •32.2.2.9 Completion of Surgery
- •32.3.1.1 Recognition
- •32.3.1.2 The Goals of Surgery
- •32.3.1.3 Instrumentation
- •32.3.1.4 Surgical Steps
- •32.3.1.5 Closed Funnel/Retinal Incarceration
- •32.3.1.6 ILM Removal
- •32.4 Subretinal Membranes/Strands
- •33.1 Retinectomy
- •34: Chromovitrectomy
- •34.1 Posterior Vitreous Cortex
- •34.3.1 False-Positive Staining with ICG
- •34.3.2 Injection Technique for Staining the ILM
- •34.4 Newly Formed (PVR) Membranes
- •35: Tamponades
- •35.2 Gases
- •35.2.1 General Considerations
- •35.2.3 Gas Injection into the Nonvitrectomized Eye
- •35.2.4 The Eye with Gaseous Tamponade
- •35.3.1 Indications to Use Heavier-Than-Water Liquids
- •35.3.2 Surgical Technique
- •35.3.2.1 Implantation
- •35.4 Silicone Oil
- •35.4.1 Selecting the Type of Silicone Oil to Implant
- •35.4.2 General Considerations
- •35.4.3 Indications
- •35.4.3.1 Semipermanent Tamponade
- •35.4.3.2 Permanent Tamponade
- •35.4.4 Implantation
- •35.4.5 With Silicone Oil in the Eye
- •35.4.5.1 General Considerations
- •35.4.5.2 Emulsification
- •35.4.6 Removal
- •35.4.6.1 Timing
- •35.4.6.2 Surgical Technique
- •35.5 Exchanges
- •35.6 If the Eye Is Aphakic
- •36: Submacular Hemorrhage
- •36.1 The Nonsurgical Approach: Intravitreal Gas and tPA
- •36.2 Removal of the Clot In Toto
- •36.4 The Minimalistic Surgical Approach
- •37: Subretinal Biopsy
- •38: Combined Surgery
- •38.1 Phacoemulsification
- •38.2 Lensectomy
- •38.2.1 Lens In Situ
- •38.3.1 Lens In Situ
- •38.3.2 Lens in Vitreous
- •38.4.2 No IOL Implantation
- •38.5 Capsule Removal
- •38.5.1 Indications
- •38.5.2 Surgical Technique
- •38.6.1 Advantages
- •38.6.2 Surgical Technique
- •38.6.3 Subsequent Sub/luxation of an Iris-Claw IOL
- •38.6.3.1 Subluxated Lens
- •38.6.3.2 Luxated Lens
- •39: AC Basics
- •39.1 Paracentesis
- •39.2 Iris Prolapse
- •39.3 Anterior Synechia
- •39.5 Material in the AC
- •40.2 Retinal Tear
- •40.3 Reopening of a Posterior Scleral Wound
- •40.4 Lens/IOL Trauma
- •41: Pediatric Patients
- •42: The Highly Myopic Eye
- •42.1 The Risk of RD If Cataract Surgery Is Needed
- •42.2 Vitrectomy in the Highly Myopic Eye
- •42.3 Posterior RD over a Staphyloma
- •43: Intravitreal Injections
- •Introduction
- •44: Dropped Nucleus and Dislocated IOL
- •44.1 General Considerations
- •44.1.2 Dislocated IOL
- •44.2 Surgical Technique
- •44.2.1 Dropped Nucleus
- •45: Endophthalmitis
- •45.1 General Considerations
- •45.1.1 Etiology
- •45.1.2 Clinical Diagnosis
- •45.1.3 Timing
- •45.1.4 Treatment Options and Management Philosophy
- •45.2 Surgical Technique
- •45.3 Posttraumatic Endophthalmitis
- •46: Floaters
- •46.1 General Considerations
- •46.1.1 Indication for Surgery
- •46.1.2 Timing of Surgery
- •46.2 Surgical Technique
- •47: Hyphema
- •47.1 General Considerations
- •47.1.1 The Rationale for Surgical Removal
- •47.1.2 Medical Treatment
- •47.2 Surgical Technique
- •47.2.1 Liquid Blood
- •47.2.1.1 Monomanual Technique
- •47.2.1.2 Bimanual Technique
- •47.2.2 Clotted Blood
- •48: Iris Abnormalities
- •48.1 General Considerations
- •48.1.2 Timing of Iris Reconstruction
- •48.2 Surgical Technique
- •48.2.2 Iridodialysis
- •48.2.3 Permanent Mydriasis
- •49: Macular Disorders: Edema
- •49.1 General Considerations
- •49.1.1 Etiology
- •49.1.2 Indications for Treatment: Surgical or Nonsurgical?
- •50.1 General Considerations
- •50.1.1 VMTS
- •50.1.2 Cellophane Maculopathy
- •50.1.3 Macular Pucker
- •50.1.4 Macular Hole
- •50.2.1 VMTS
- •50.2.2 Cellophane Maculopathy
- •50.2.3 Macular Pucker
- •50.2.4 Macular Hole
- •50.2.5 If Surgery Failed for a Macular Hole
- •51: Optic Pit
- •51.1 General Considerations
- •51.2 Surgical Technique
- •52.1 General Considerations
- •52.1.1 Indications
- •52.1.2 Preoperative Considerations
- •52.2 Surgical Technique
- •53.1 General Considerations
- •53.2 Surgical Technique
- •54: Retinal Detachment
- •54.1.1 RD Due to a Horseshoe or Giant Tear
- •54.1.2 RD Due to a Dialysis
- •54.1.3 RD Due to a Round Hole
- •54.1.4 RD Due to a Staphyloma
- •54.2 Additional Information About RD
- •54.2.1 History
- •54.2.3 Clinical Course
- •54.2.4 Using Laser to Prevent RD Development
- •54.2.4.1 Prophylaxis in the Affected Eye (RD, Current or Past)
- •54.2.4.2 Prophylaxis in the Fellow Eye
- •54.2.4.3 The Patient with a History of a Retinal Tear (No RD)
- •54.3 Treatment Principles
- •54.3.2 The Goals of Surgery
- •54.3.3 Prognosis
- •54.4.1 Preoperatively
- •54.4.2.1 Initial Steps
- •54.4.2.2 Creating a Chorioretinal Adhesion
- •54.4.2.3 Drainage of the Subretinal Fluid
- •54.4.2.5 Suturing
- •54.4.2.7 Adjusting the Buckle
- •54.4.2.8 Closing the Conjunctiva
- •54.4.2.9 Gas Tamponade
- •54.4.3 Major Intraoperative Complications of SB
- •54.5 Vitrectomy
- •54.5.2.3 Intraoperative Retinal Reattachment
- •54.5.2.4 Laser Retinopexy
- •54.5.2.5 Intraocular Tamponade
- •54.5.2.6 Postoperative Positioning
- •54.5.3 Follow-Up Visits
- •54.5.4 Prognosis
- •54.5.5 RD After Silicone Oil Removal
- •54.6 Pneumatic Retinopexy
- •54.6.1 General Considerations
- •54.6.2 Patient Selection
- •54.6.3 Surgical Options
- •54.6.3.1 Cryopexy, Followed by Gas Injection
- •54.6.3.2 Gas Injection, Followed by Laser
- •54.7 Reoperation
- •55: RD, Tractional and Combined
- •55.1.1 Characteristics of the RD
- •55.1.2 Management Principles
- •56: RD, Central
- •56.1 General Considerations
- •56.2 Surgical Technique
- •57: Retinoschisis
- •57.1.1 Anatomy and Pathophysiology
- •57.1.2 Prophylactic Laser Treatment
- •57.2 Surgical Technique
- •58.1 General Considerations
- •58.1.1 Treatment Options
- •58.1.2 The Vitrectomy Option
- •58.2 Surgical Technique
- •59: Scleroplasty
- •59.1 General Considerations
- •59.2 Surgical Technique
- •60: Suprachoroidal Hemorrhage
- •60.1.1 Indications for Surgery
- •60.1.2 Timing of Surgery
- •60.2 Surgical Technique
- •61: Uveitis, Posterior
- •62: Vitreous Hemorrhage
- •62.1 General Considerations
- •62.2 Surgical Technique
- •62.3 Severe Bleeding in a Young Patient
- •62.4 Rebleeding in a Vitrectomized Eye
- •63: Trauma
- •63.1 The Timing of Surgery
- •63.2 Contusion
- •63.3 Wound Toilette
- •63.5 Suturing the Sclera
- •63.6 Subluxated Lens
- •63.7 IOFB
- •63.7.2 Posterior Segment
- •63.8 Perforating Trauma and Ruptures
- •63.9 NLP and Sympathetic Ophthalmia
- •63.11 Hemorrhagic RD
- •63.12 Additional Considerations
- •64: Postoperative Care
- •Further Reading
- •Appendix
- •Part 2. Important Personal Experiences
14.3 Silicone Oil |
117 |
|
|
Fig. 14.1 Pneumovitrectomy for the “vitreous skirt” in the periphery. The image is slightly different in the air-filled eye if vitreous is still present. On the left side, pneumovitrectomy has already been done and the remaining vitreous skirt is greatly trimmed; to the right, where the probe is held, the skirt is still rather thick. All this is readily visible under air; if BSS is used, the remaining vitreous is largely unnoticeable
Complications9: High IOP (see above) and cataract; the latter (“gas cataract”) may be temporary (see Fig. 14.2). Rarely, a visual field defect develops.10 Gases may also enter the subretinal space, but this is less common than with air, due to the high surface tension of the gas.
Fig. 14.2 Gas cataract. Typical image of the lens feathering due to long vitrectomy or gas implantation. With very rare exceptions, the condition resolves spontaneously with time
14.3Silicone Oil
Providing long-term11 tamponade, the oil can be both a prophylactic and a therapeutic tool.
9Employing gas of erroneous concentration (see Chap. 6) is a complication due not to the gas but to the nurse (just remember, it is still the surgeon who is ultimately held responsible for it).
10Probably due to the drying of the retinal surface.
11Weeks, months, or permanent, depending on the indication and the eye’s condition, see Table 14.1.
118 |
|
14 Materials and Their Use |
|
||
Table 14.1 Duration options of silicone oil tamponade |
||
Duration |
Common conditionsa |
Comment |
Weeks |
Macular hole |
This period should be sufficiently long to |
|
|
achieve hole closureb; if the hole |
|
|
remains open after a month or so, it is |
|
|
unlikely to close even if the silicone oil |
|
|
is retained for longer |
Monthsc |
RD |
Large (giant) or multiple breaks, unsuccessful |
|
|
RD surgery on the fellow eye |
|
|
Typical duration of tamponade: at least 3 |
|
|
months |
|
PVR present |
The most effective weapon to keep the |
|
|
retina attached. Having significant |
|
|
amount of pigment in the vitreous is an |
|
|
indicator of more severe PVR to develop |
|
|
(see Fig. 53.1) |
|
|
Typical duration of tamponade: 3–6 months |
|
PVR expected (prophylaxis) |
The silicone oil acts as a space-occupying |
|
|
tool |
|
|
Typical duration of tamponade: ~3 months |
|
PDR |
The most effective weapon to keep the |
|
|
retina attached; the oil also helps |
|
|
prevent VH |
|
|
Typical duration of tamponade: 3–6 months |
|
Endophthalmitis |
If the retina is detached or damaged |
|
|
(break/s, necrosis) or if, due to the |
|
|
reaccumulation of debris, postoperative |
|
|
visibility of the retina is expected to be |
|
|
poor |
|
|
Typical duration of tamponade: ~3 months |
Permanent |
Recurrent/nontreatable RD |
The oil is the only tool that may be able to |
(forever)d |
|
prevent further deterioration of the |
|
|
condition (RD, recurrent VH). |
|
|
Periodically, the silicone oil must be |
|
|
exchanged |
|
Severe hypotony, phthisical eye |
The oil is the only tool that may be able to |
|
|
prevent further deterioration of the |
|
|
condition. Periodically, the silicone oil |
|
|
must be exchanged |
|
|
It is best to make the eye aphakic and the |
|
|
“100% fill” means 100% for the entire |
|
|
eyeball, not only the vitreous cavitye |
aOnly a selected few examples are included here.
bThere is no need for positioning as long as the fill is 100%.
cIt is rather common that, due to the recurrence of the condition, “oil exchange” is necessary, extending or multiplying the periods with silicone oil fill.
dOn a personal note: This is my only indication to use 5,000 cst oil. eSee Sect. 13.3.1 for more details.
14.3 Silicone Oil |
119 |
|
|
14.3.1 Types of Silicone Oil
•Viscosity: The two typical options are 1,000/1,300 cst and ≥5,000 cst.
–Higher viscosity is assumed to delay the time to emulsification.12
–The higher the viscosity, the more difficult to inject, and especially extract, the oil.
•Molecular weight: Standard vs “heavy” silicone oil.
–The standard oil13 has a specific gravity of 0.97: it floats on water (BSS, aqueous).
–The “heavy” oil has a specific gravity of 1.02–1.06: it sinks in water (BSS, aqueous).
14.3.2 Achieving a 100% Fill14
The oil is supposed to be in contact with the retina,15 ciliary body, zonules, and the posterior capsule (iris in the aphakic eye) over their entire surface. To achieve this, the surgeon needs to do the following.
•A meticulous exchange between the current intravitreal content (typically air) to silicone oil.
–In fact, the goal is a slight overfill, as measured by the IOP,16 to compensate for the postoperative increase in the volume of the vitreous cavity.17
Q&A
Q What is the true benefit of a 100% silicone oil fill?
AIn principle, cells cannot accumulate and proliferative membranes cannot form: the risk of PVR development is reduced.
•Prevention of silicone oil loss at the time of cannula removal (see Fig. 14.3).
– A second reason for this is to prevent oil accumulation under the conjunctiva.18
12The key word here is “assumed.” Emulsification depends on many other factors as well, and it is not uncommon to see early emulsification even with higher viscosity oils.
1337 kDa molecular weight as opposed to the 74 kDa molecular weight of a heavy oil.
14The technical details are provided in Sect. 35.4.
15A scleral buckle represents too great a change in the curvature of the eyewall for the silicone oil to follow; in an oil-filled eye there is always a small ring of aqueous at the bottom of the central slope of the indentation.
16I typically aim for 30 mmHg.
17The temporary, intraoperative “loss” of the volume of the vitreous cavity is caused by increased choroidal thickness due to increased blood flow. Additional factors may include epiretinal blood, posterior dislocation of the iris/lens diaphragm (e.g., due to air or viscoelastics in the AC) etc.
18Which can give foreign-body sensation to the patient; young women also often complain about the eye “looking ugly” (see Sect. 35.4.4).
120 |
14 Materials and Their Use |
Fig. 14.3 The double-loop |
a |
suture to close the sclerot- |
|
omy to avoid silicone oil |
|
loss. (a) Entry (1, 3) and exit |
4 |
(2, 4) points of the needle; |
|
the numbers represent the |
|
proper sequence. (b) The |
1 |
appearance of the suture once |
2 |
the threads have been cut |
3 |
|
b
If the fill is incomplete, a crescent of aqueous is found, in the erect patient, at the bottom of the eye.19 Inflammatory debris collects in this pool of fluid, increasing the risk of PVR.
Pearl
The use of heavy silicone oil shifts the pool of fluid superiorly. With the use of standard oil, the PVR starts inferiorly; it is shifted superiorly with heavy oil (see Table 14.2).
With silicone oil use, there are important questions related to the lens20 (see
Table 14.3).
19Depending on the degree of the underfill and the size of the pupil, the oil meniscus can actually be visible at the slit lamp.
20The surgeon must keep in mind that an unexpected complication can always force him to implant silicone oil, even if this was never in the original plan.
14.3 Silicone Oil |
|
|
|
121 |
|
||||
Table 14.2 Clinical implications of an underfill with silicone oils of different weight |
||||
Variable |
Standard oil |
|
Heavy oil |
|
Consequence: |
Fluid pooling inferiorly |
|
Fluid pooling superiorly |
|
always |
|
|
|
|
Consequence: |
Cell proliferation, membrane |
|
Cell proliferation, membrane |
|
potentially |
formation inferiorly |
|
formation superiorly |
|
|
PVR/RD inferiorly with a relative |
PVR/RD superiorly with a relative |
||
|
visual field defect superiorly |
visual field defect inferiorly |
||
Reoperation for |
Retinectomy (+silicone oil |
|
Retinectomy (+silicone oil |
|
PVR/RDa |
reimplantation) |
|
reimplantation) |
|
Reoperation: |
Partial loss of the upper visual field |
Partial loss of the lower visual field |
||
Implications for |
(less important in everyday life, |
(more important in everyday |
||
patient |
but the loss may be rather |
|
life, but the loss may be less |
|
|
extensive due to multiple |
|
extensive if the previous |
|
|
retinectomies) |
|
retinectomy was inferior) |
|
Reoperation: |
Technically, access to all of the |
Technically, access to the superior |
||
Implications for |
inferior retina is rather easy |
retina is more difficult |
||
surgeon |
|
|
|
|
Removal of the oil |
Technically easy |
|
Technically more difficult |
|
aAdding an SB is not considered here |
|
|
||
Table 14.3 Silicone oil and the lens |
|
|
||
Issue/question |
|
Comment/answer |
Rationale |
|
If the eye is (to remain) |
Yes |
The need for silicone oil use may become |
||
phakic, should you |
|
|
necessary only during, not before, |
|
nevertheless do biometry |
|
surgery |
||
prior to the PPV? |
|
|
Biometry is less reliable in the silicone |
|
|
|
|
oil-filled eyea |
|
Should you remove the lens |
Yes/no |
Yes if the eye does not have useful |
||
in each eye undergoing |
|
accommodationb or the silicone oil is |
||
PPV if you know that |
|
likely to be needed forever |
||
silicone oil will be |
|
|
Yes if cataract is expected to develop while |
|
implanted? |
|
|
the oil is in the eye |
|
|
|
|
No if the patient is young with useful |
|
|
|
|
accommodation |
|
Should you leave the eye |
Yes/no |
Yes if there is a very high risk of |
||
aphakic? |
|
|
postoperative PVR or the eye is highly |
|
|
|
|
myopic.c A 6 o’clock iridectomy must |
|
|
|
|
always be performed (see Sect. 35.6) |
|
|
|
|
No in every other case |
|
If you do implant an IOL, |
Yes |
The capsule may opacify prior to oil |
||
should you perform a |
|
removal, which may be as much a |
||
posterior capsulectomy? |
|
hindrance to visualization of the retina |
||
|
|
|
as cataract development would be |
|
If you do implant an IOL, |
An eye without |
You are certain preoperatively that you |
||
what calculation do you |
silicone oil, |
will never be able to remove the oil. |
||
use: assuming oil |
|
unless |
The possibility of this, however, must |
|
retention or removal? |
|
always be discussed with the patient |
||
|
|
|
preoperatively (see Chap. 5) |
|
aSee Sect. 4.5.
bEmmetropic eye and a patient over 45–50 years of age; different answers apply in cases of hyperopia or low myopia, and younger age; the patient should decide.
cNot needing refractive correction. This may be controversial suggestion, but I fail to see the benefit of implanting a 0 D IOL (see Sect. 42.1).
- #28.03.202639.38 Mб0The Wills eye manual office and emergency room diagnosis and treatment of eye disease Adam T. Gerstenblith, Michael P. Rabinowitz.chm
- #
- #
- #
- #
- #
- #
- #28.03.202614.01 Кб0[Офтальмология] Jack J. Kanski Джек Дж. Кански - Клиническая офтальмология систематизированный подход [2006, PDF DjVu, RUS] [rutracker-5395873].torrent
- #
- #
- #
